An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease
Clinical trial NCT00814801 · COMPLETED
Trial details
- NCT number
- NCT00814801
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-09-01
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.